PK-treated CFS also significantly reduced IL-6 compared to both the untreated CFS in MRS and TIL (p < 0.0001) and TRY-digested CFS in MRS (p < 0.0001). This evidence concerns the gene IL6 and myalgic encephalomeyelitis/chronic fatigue syndrome.